Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-03-07 / Breast Cancer Res. 2012 Mar;14(2):R39Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2012-03-01 / J Hepatobiliary Pancreat Sci 2012 Mar;19(2):171-8Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge era
/in Dendritic Cells, International Publications, Prostate Cancer /von 2012-03-01 / Expert Rev Vaccines 2012 Mar;11(3):287-302Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2012-03-01 / Pancreas 2012 Mar;41(2):195-205Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 2012-01-26 / Cancer Immunol. Immunother. 2012 Sep;61(9):1407-13HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-17 / Cancer 2012 Sep;118(17):4354-62Immunotherapy for metastatic colorectal cancer: present status and new options
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2012-01-03 / Scand. J. Gastroenterol. 2012 Mar;47(3):315-24Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-01-01 / Cell Biochem. Biophys. 2012 Jan;62(1):91-9A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2012-01-01 / J Immunother 2012 Jan;35(1):54-65
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de